These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12874874)

  • 1. Study of the development of chemoresistance in melanoma cell lines using proteome analysis.
    Sinha P; Poland J; Kohl S; Schnölzer M; Helmbach H; Hütter G; Lage H; Schadendorf D
    Electrophoresis; 2003 Jul; 24(14):2386-404. PubMed ID: 12874874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis.
    Sinha P; Kohl S; Fischer J; Hütter G; Kern M; Köttgen E; Dietel M; Lage H; Schnölzer M; Schadendorf D
    Electrophoresis; 2000 Aug; 21(14):3048-57. PubMed ID: 11001322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
    Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
    Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of therapy resistance in cancer cells with functional proteome analysis.
    Poland J; Schadendorf D; Lage H; Schnölzer M; Celis JE; Sinha P
    Clin Chem Lab Med; 2002 Mar; 40(3):221-34. PubMed ID: 12005211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
    Yan XD; Pan LY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Up- and Down-Regulated Proteins in Pemetrexed-Resistant Human Lung Adenocarcinoma: Flavin Reductase and Calreticulin Play Key Roles in the Development of Pemetrexed-Associated Resistance.
    Chou HC; Chen JY; Lin DY; Wen YF; Lin CC; Lin SH; Lin CH; Chung TW; Liao EC; Chen YJ; Wei YS; Tsai YT; Chan HL
    J Proteome Res; 2015 Nov; 14(11):4907-20. PubMed ID: 26452990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs.
    Grottke C; Mantwill K; Dietel M; Schadendorf D; Lage H
    Int J Cancer; 2000 Nov; 88(4):535-46. PubMed ID: 11058868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of proteomics to study chemosensitivity.
    Poland J; Wandschneider S; Urbani A; Bernardini S; Federici G; Sinha P
    Methods Mol Med; 2005; 111():267-81. PubMed ID: 15911985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431.
    Castagna A; Antonioli P; Astner H; Hamdan M; Righetti SC; Perego P; Zunino F; Righetti PG
    Proteomics; 2004 Oct; 4(10):3246-67. PubMed ID: 15378690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.
    Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G
    Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of DNA repair proteins hMSH2, hMSH6, hMLH1, O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistance.
    Lage H; Christmann M; Kern MA; Dietel M; Pick M; Kaina B; Schadendorf D
    Int J Cancer; 1999 Mar; 80(5):744-50. PubMed ID: 10048977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential proteomic analysis of drug resistant A549/DDP cell lines in human lung adenocarcinoma].
    Wei R; Xie Y; Yang D; He L; Peng F; Sheng L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 35(8):854-60. PubMed ID: 20818079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the development of thermoresistance in human pancreatic carcinoma cell lines using proteome analysis.
    Poland J; Urbani A; Lage H; Schnölzer M; Sinha P
    Electrophoresis; 2004 Jan; 25(1):173-83. PubMed ID: 14730581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cisplatin administration on protein expression levels in renal cell carcinoma: a proteomic analysis.
    Vasko R; Mueller GA; von Jaschke AK; Asif AR; Dihazi H
    Eur J Pharmacol; 2011 Nov; 670(1):50-7. PubMed ID: 21924258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer.
    Zhang D; Tai LK; Wong LL; Chiu LL; Sethi SK; Koay ES
    Mol Cell Proteomics; 2005 Nov; 4(11):1686-96. PubMed ID: 16048908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
    J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
    Kissel CK; Schadendorf D; Röckmann H
    Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide.
    Rünger TM; Emmert S; Schadendorf D; Diem C; Epe B; Hellfritsch D
    J Invest Dermatol; 2000 Jan; 114(1):34-9. PubMed ID: 10620112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs.
    Chuthapisith S; Layfield R; Kerr ID; Hughes C; Eremin O
    Int J Oncol; 2007 Jun; 30(6):1545-51. PubMed ID: 17487377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proteomic analysis of cisplatin resistance in breast cancer cells.
    Smith L; Welham KJ; Watson MB; Drew PJ; Lind MJ; Cawkwell L
    Oncol Res; 2007; 16(11):497-506. PubMed ID: 18306929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.